NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery.

Author(s): Zhou H, Yuen P S, Pisitkun T, Gonzales P A, Yasuda H, Dear J W, Gross P, Knepper M A, Star R A

Publication: Kidney Int, 2006, Vol. 69, Page 1471

PubMed ID: 16501490 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to evaluate methodology pertaining to the collection (time of day, addition of protease inhibitors), and storage and preservation (temperature and duration) of urinary exosome proteins.

Conclusion of Paper

Addition of protease inhibitors to the urine biospecimen was required to preserve exosome protein expression patterns, while first and second morning urine collections yielded similar results. Storage-dependent decreases in protein recovery and exosome protein expression were observed (-20 degrees C versus 4 and -80 degrees C), but were attenuated by sample vortexing after thawing. Long-term storage (7 months at -80 degrees C) yielded comparable results to fresh specimens when vortexed after thawing.

Studies

  1. Study Purpose

    The purpose of this experiment was to determine whether protease inhibitors are necessary for preservation of NKCC2 in urine.

    Summary of Findings:

    Specimens without protease inhibitors exhibited decreased or absent NKCC2 signal compared to those with protease inhibitors.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Western blot
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Analyte Extraction and Purification Protease inhibitor With protease inhibitors
    Without protease inhibitors
  2. Study Purpose

    The purpose of this study was to determine the influence of storage temperature and duration on urinary exosome proteins (NHE3, TSG101, ALIX, and AQP2), and to further determine whether 10 ml biospecimens provide sufficient starting material to detect urinary exosome proteins.

    Summary of Findings:

    Storage temperature robustly affected recovery of exosome proteins, 27% and 86% recovery at -20 and -80 degrees C for 1 week, respectively, when compared to storage of controls at 4 degrees C for 1 hour; however, vortexing for 90 seconds after thawing improved recovery significantly, 87-100%. Western blot analysis confirmed the results above, as the absence of NHE3, TSG101, and ALIX in urine stored at -20 degrees C was attenuated with extensive vortexing. Further, NHE3, TSG101, ALIX, and AQP2 were detectable in urine aliquots as small as 10 ml. Vortexing urine samples stored at -80 degrees for 7 months yielded exosome protein expression comparable to fresh samples, with the exception of ALIX, which displayed individual variability independent of storage duration.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Western blot
    Protein 1D/2D gels
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot size/volume 300 ml
    10 ml
    Storage Storage duration 1 week
    7 months
    1 h
    Storage Storage temperature 4 degrees C
    -20 degrees C
    -80 degrees C
  3. Study Purpose

    The purpose of this study was to evaluate whether first morning urine was significantly different from second urine of the day in terms of the detectable level of exosomes.

    Summary of Findings:

    Total protein amounts were similar among first and second morning urine specimens. When normalized for urine flow rate or urine creatinine levels, the abundance of four exosome proteins (NHE3, TSG101, ALIX, and AQP2) were similar in first and second morning urines.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Protein Western blot
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot sequential collection First urine of the day
    Second urine of the day

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...